Skip to main content
Fig. 1 | BMC Rheumatology

Fig. 1

From: Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

Fig. 1

This figure represents the Markov Structure of the initial combination strategy. MTX combi low: low dose csDMARD combination therapy; MTX combi high: High dose csDMARD combination therapy; Biological 1,2,3: bDMARD therapy. High DAS: High DAS28, Moderate DAS: Moderate DAS28; Low DAS: Low DAS28; Next Drug: patients move downstream; Remission: in case of sustained remission medication will be tapered, in case of only 1 cycle in remission, patient continues the same treatment

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us